Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04567030Recruiting
AI tool to help improve gum treatment outcomes
This trial tests whether an artificial intelligence (AI) system can help plan and improve results of gum (periodontal) treatment. You may be a good match if you have diagnosed periodontal disease and enough healthy teeth.
Kaohsiung CityAges 35–65 - NCT06120049RecruitingPhase 2/Phase 3
Comparing new PET scans for Parkinson's, MSA, Lewy body dementia, and Alzheimer's
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
Ghent, GentAges 18–85 - NCT06083649Recruiting
Dental education: AI vs. human counseling for gum disease
This trial compares two ways of teaching about dental care—AI-assisted education versus speaking with a counselor—to see which one helps people with gum disease better control plaque and improve treatment outcomes.
Kaohsiung CityAges 35–65 - NCT06715085RecruitingPhase 4
PRGF injections for chronic low back pain
This trial tests whether injections of a blood-based treatment called PRGF can help people with long-term low back pain caused by worn discs. It is for those who haven't gotten relief from standard treatments like medication.
Vitoria-Gasteiz, AlavaAges 18 years+ - NCT07431437Enrolling by invitation
GENOSS paclitaxel balloon for leg artery disease
This trial tests a special balloon coated with paclitaxel (a drug that helps keep arteries open) in people with narrowed or blocked leg arteries. It aims to see how well the balloon works over one year.
Seoul, SeoulAges 19–85 - NCT07432958RecruitingPhase 2
Study of AP-472 with levodopa for Parkinson's motor fluctuations
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
Little Rock, ArkansasAges 30–80 - NCT06812091Recruiting
Study on microbiome in children
This study explores the role of the microbiome (the community of bacteria in our bodies) in children's health. It aims to develop new treatments for pediatric diseases.
SeoulAges Any age - NCT07434089Recruiting
Walking therapy and gut health in Parkinson's
This trial tests how a special treadmill (C-Mill) training affects the connection between your brain and gut in Parkinson's disease. It may help improve walking and gut symptoms.
Messina, MessinaAges 40–70 - NCT07428577Recruiting
Tracking care for advanced HIV patients after hospital stay
This trial looks at whether staying in contact with patients after they leave the hospital helps them get better follow-up care. If you have advanced HIV and are in the hospital for a related illness, you may be able to join.
Johannesburg, GautengAges 18 years+ - NCT07427108Recruiting
Road map vs. ultrasound for retrograde leg angioplasty
This trial compares two imaging methods (road map vs. ultrasound) to guide a needle puncture from the ankle area during angioplasty for blocked leg arteries. It aims to see which method is safer and more effective for patients with severe leg wounds or ulcers that need this retrograde approach.
SohagAges 18 years+ - NCT07431606RecruitingPhase 2
Duloxetine for Inflammatory Bowel Disease
This study tests whether duloxetine, a medication used for pain and mood, can help people with inflammatory bowel disease (IBD) who are also dealing with high stress, disability, or gut-related anxiety.
Philadelphia, PennsylvaniaAges 24 years+ - NCT07432828Recruiting
Sleep problems and heart disease: a study link
This study looks at how sleep issues (like trouble sleeping or feeling very sleepy during the day) might be related to heart conditions. If you see a heart doctor, you can help by filling out a simple questionnaire about your sleep.
Carquefou, FranceAges 18 years+ - NCT07427498Recruiting
How beliefs affect hallucinations in Parkinson's disease
This study looks at how your past experiences and expectations might influence visual hallucinations if you have Parkinson's disease. It involves cognitive tests and compares people with and without hallucinations, as well as healthy volunteers.
GrenobleAges 18–85 - NCT06813534Recruiting
IVUS-guided stent placement for kidney disease patients
This trial tests whether using a special ultrasound camera inside the artery (IVUS) to guide stent placement can improve outcomes for people with serious kidney disease. The goal is to use less contrast dye and protect the kidneys better.
Créteil, CreteilAges 18 years+ - NCT06813443Recruiting
Studying cardiomyopathy to find who needs a heart transplant
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
Bologna, Emilia-Romagna/BolognaAges 12 years+ - NCT06002932Recruiting
Comparing one-stent with drug balloon vs. two-stents for heart artery branches
This study compares two ways to treat a narrowed heart artery where a smaller branch vessel is also blocked. One approach uses a drug-coated balloon on the side branch, while the other places a second stent. The goal is to see which method works better for patients like you.
Suwon, Gyeonggi-doAges 19 years+ - NCT06256393Recruiting
Studying inflammatory bowel disease in Nantes
This study collects information and samples from people with active inflammatory bowel disease who need surgery or an endoscopy. It aims to better understand these conditions and improve future treatments.
NantesAges 18 years+ - NCT06581770Recruiting
Turkish Digital Health Readiness Questionnaire Study
This study tests a Turkish version of a questionnaire about how ready people are to use digital health tools. It is for Turkish-speaking adults with chronic conditions like obesity, diabetes, heart disease, or lung disease.
Istanbul, IstanbulAges 18 years+ - NCT07419828RecruitingPhase 3
Study of HRS-1780 for chronic kidney disease
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
Nanjing, JiangsuAges 18–80 - NCT07425171Recruiting
Testing a drug-coated balloon for long leg artery blockages
This trial is testing a special balloon coated with the drug paclitaxel to open up long blockages in the leg artery (femoropopliteal). The goal is to see if it is safe and effective for improving blood flow and symptoms like pain or ulcers.
Suwon, Gyeonggi-doAges 19–85 - NCT07420907Recruiting
Tracking heart health over time
This study uses a wearable patch to monitor heart-related signs in people with heart conditions. It aims to learn more about how these conditions progress, which could help improve future care.
Chicago, IllinoisAges 18 years+ - NCT07419334RecruitingPhase 3
Study of a new drug for Stargardt disease
This trial tests a new drug, ALK-001, to see if it can slow down vision loss from Stargardt disease. It is for people who have a confirmed genetic diagnosis and are between 8 and 45 years old.
Phoenix, ArizonaAges 8–45 - NCT07418736RecruitingPhase 2
CM326 for moderate to severe COPD
This trial tests a new medicine called CM326 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve lung function.
Beijing, Beijing MunicipalityAges 40–85 - NCT06816615Recruiting
Treating gallstones and bile duct problems through the skin
This trial tests a new way to diagnose and treat gallstones or bile duct narrowing without surgery, using a needle through the skin (percutaneous treatment). It is for people whose condition could not be fixed with an endoscope.
Bologna, BOAges 18 years+
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,359 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.